Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- What Next For Food Supplements In Europe? Conference: Food Supplements in Europe, Challenges for the Future
Government representatives from the food and health sectors of more than twenty EU and non-EU countries met with the European Commission, scientific experts and the food supplement industry in Berlin in September to debate the next stages of development of the regulatory environment for Food Supplements; delegates explored common approaches on the setting of maximum levels for vitamins and minerals, the substantiation of health claims , and potential models for the safety
assessment of ingredients other than vitamins and minerals.
- NBTY, Inc. to Pay $2 Million Penalty For Alleged Violations of FTC Order
Under the terms of a consent decree approved by the Federal Trade Commission, for submission by the U.S. Department of Justice to the federal court for approval, NBTY, Inc. will pay a $2 million civil penalty to settle charges that it violated the terms of a 1995 Commission order by making false and misleading health claims about two of its products - “Royal Tongan Limu" and “Body Success PM Diet Program”.
- NBTY, Inc. to Pay $2 Million Penalty For Alleged Violations of FTC Order
Under the terms of a consent decree approved by the Federal Trade Commission, for submission by the U.S. Department of Justice to the federal court for approval, NBTY, Inc. will pay a $2 million civil penalty to settle charges that it violated the terms of a 1995 Commission order by making false and misleading health claims about two of its products - “Royal Tongan Limu" and “Body Success PM Diet Program”.
- Food Allergen Labeling Law Effective January 1 for All Foods and Dietary Supplements
Any food (including dietary supplements) that contains a major food allergen must include specific warnings when labeled on or after January 1, 2006; AHPA to hold tele-seminar on the new requirement at the end of November, with a repeat session in early December.
- Food Allergen Labeling Law Effective January 1 for All Foods and Dietary Supplements
Any food (including dietary supplements) that contains a major food allergen must include specific warnings when labeled on or after January 1, 2006; AHPA to hold tele-seminar on the new requirement at the end of November, with a repeat session in early December.
- Food Allergen Labeling Law Effective January 1 for All Foods and Dietary Supplements
Any food (including dietary supplements) that contains a major food allergen must include specific warnings when labeled on or after January 1, 2006; AHPA to hold tele-seminar on the new requirement at the end of November, with a repeat session in early December.
- Food Allergen Labeling Law Effective January 1 for All Foods and Dietary Supplements
Any food (including dietary supplements) that contains a major food allergen must include specific warnings when labeled on or after January 1, 2006; AHPA to hold tele-seminar on the new requirement at the end of November, with a repeat session in early December.
- AER Amendment Dropped from Senate Defense Bill
Following discussion on the Senate floor last week, Senator Richard Durbin (D-IL) won a commitment from the chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee to prioritize efforts to pass legislation requiring supplement manufacturers to submit serious adverse event reports (AERs) to the Food and Drug Administration (FDA).
- AER Amendment Dropped from Senate Defense Bill
Following discussion on the Senate floor last week, Senator Richard Durbin (D-IL) won a commitment from the chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee to prioritize efforts to pass legislation requiring supplement manufacturers to submit serious adverse event reports (AERs) to the Food and Drug Administration (FDA).
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- FDA Warns Companies To Stop Marketing Fruit Products With Unproven Disease Treatment and Prevention Claims
The Food and Drug Administration (FDA) issued Warning Letters to 29 companies that manufacture, market, or distribute products made from cherries or other fruits, telling the firms to stop making unproven claims on the firms’ web sites and product labels that their fruit products treat or prevent disease.
- United States, Mexico, Canada (MUCH) Combat Weight Loss Fraud
Under a Trilateral Cooperation Charter agreement between the United States, Mexico, and Canada signed in 2003, six agencies (two from each country) today announced that they have taken nearly 730 compliance actions against companies that they allege promote bogus and misleading weight loss schemes that endanger public health, provide false hope, and defraud citizens of billions of dollars.
- United States, Mexico, Canada (MUCH) Combat Weight Loss Fraud
Under a Trilateral Cooperation Charter agreement between the United States, Mexico, and Canada signed in 2003, six agencies (two from each country) today announced that they have taken nearly 730 compliance actions against companies that they allege promote bogus and misleading weight loss schemes that endanger public health, provide false hope, and defraud citizens of billions of dollars.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Final Dietary Supplement cGMP at OMB; AHPA to Offer Training through Teleseminars
The Office of Management and Budget (OMB) has recorded that it has received the final good manufacturing practice (cGMP) rule for dietary supplements for review.
- Enzymotec Gains GRAS in the US For CardiaBeat
CardiaBeat (TM), the company's advanced sterol-based ingredient, has recently gained a GRAS affirmation by an expert panel, allowing its use in a wide variety of food applications.
- Enzymotec Gains GRAS in the US For CardiaBeat
CardiaBeat (TM), the company's advanced sterol-based ingredient, has recently gained a GRAS affirmation by an expert panel, allowing its use in a wide variety of food applications.
- Enzymotec Gains GRAS in the US For CardiaBeat
CardiaBeat (TM), the company's advanced sterol-based ingredient, has recently gained a GRAS affirmation by an expert panel, allowing its use in a wide variety of food applications.
- Enzymotec Gains GRAS in the US For CardiaBeat
CardiaBeat (TM), the company's advanced sterol-based ingredient, has recently gained a GRAS affirmation by an expert panel, allowing its use in a wide variety of food applications.
- Enzymotec Gains GRAS in the US For CardiaBeat
CardiaBeat (TM), the company's advanced sterol-based ingredient, has recently gained a GRAS affirmation by an expert panel, allowing its use in a wide variety of food applications.
- Enzymotec Gains GRAS in the US For CardiaBeat
CardiaBeat (TM), the company's advanced sterol-based ingredient, has recently gained a GRAS affirmation by an expert panel, allowing its use in a wide variety of food applications.
- Herbs of Commerce, 2nd edition, Becomes Law of the Land for Labeling
Effective January 1, 2006, AHPA’s Herbs of Commerce, 2nd edition, will be officially incorporated into federal regulations on labeling of botanical ingredients in dietary supplement, when a direct final rule published in 2003 goes into effect.
- Herbs of Commerce, 2nd edition, Becomes Law of the Land for Labeling
Effective January 1, 2006, AHPA’s Herbs of Commerce, 2nd edition, will be officially incorporated into federal regulations on labeling of botanical ingredients in dietary supplement, when a direct final rule published in 2003 goes into effect.
- Herbs of Commerce, 2nd edition, Becomes Law of the Land for Labeling
Effective January 1, 2006, AHPA’s Herbs of Commerce, 2nd edition, will be officially incorporated into federal regulations on labeling of botanical ingredients in dietary supplement, when a direct final rule published in 2003 goes into effect.
- Herbs of Commerce, 2nd edition, Becomes Law of the Land for Labeling
Effective January 1, 2006, AHPA’s Herbs of Commerce, 2nd edition, will be officially incorporated into federal regulations on labeling of botanical ingredients in dietary supplement, when a direct final rule published in 2003 goes into effect.
- FTC Stops Bogus Ads for 'Bio Trim' and Other Weight-loss Products
Under the terms of a consent agreement approved by the Federal Trade Commission and announced today, Tustin, California based Natural Products, LLC, All Natural 4 U, LLC and their owner, Ana M. Solkamans, are permanently prohibited from making false and misleading claims about weight-loss products, including a dietary supplement they marketed as “Bio Trim,” “Body-Trim/Bio-Trim,” and “Body-Trim.”
- FTC Stops Bogus Ads for 'Bio Trim' and Other Weight-loss Products
Under the terms of a consent agreement approved by the Federal Trade Commission and announced today, Tustin, California based Natural Products, LLC, All Natural 4 U, LLC and their owner, Ana M. Solkamans, are permanently prohibited from making false and misleading claims about weight-loss products, including a dietary supplement they marketed as “Bio Trim,” “Body-Trim/Bio-Trim,” and “Body-Trim.”
- BCIT offers Natural Health Products Course in Good Manufacturing Practices for Natural Health Products
The British Columbia Institute of Technology (BCIT) is offering a four-day industry course in Good Manufacturing Practices for Natural Health Products from November 14th to 17th at their Burnaby campus. Registration Deadline is Wednesday, Nov 9, 2005.
- BCIT offers Natural Health Products Course in Good Manufacturing Practices for Natural Health Products
The British Columbia Institute of Technology (BCIT) is offering a four-day industry course in Good Manufacturing Practices for Natural Health Products from November 14th to 17th at their Burnaby campus. Registration Deadline is Wednesday, Nov 9, 2005.
- BCIT offers Natural Health Products Course in Good Manufacturing Practices for Natural Health Products
The British Columbia Institute of Technology (BCIT) is offering a four-day industry course in Good Manufacturing Practices for Natural Health Products from November 14th to 17th at their Burnaby campus. Registration Deadline is Wednesday, Nov 9, 2005.
- BCIT offers Natural Health Products Course in Good Manufacturing Practices for Natural Health Products
The British Columbia Institute of Technology (BCIT) is offering a four-day industry course in Good Manufacturing Practices for Natural Health Products from November 14th to 17th at their Burnaby campus. Registration Deadline is Wednesday, Nov 9, 2005.
- FDA/FTC Join Regulatory Efforts against Hormone-Related Product Claims
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have announced actions against a number of companies marketing unapproved “alternative hormone therapies,” targeting unproven disease claims; FDA said it has sent Warning Letters to 16 dietary supplement and hormone cream marketers; FTC is issuing letters that notify 34 websites that include unsubstantiated claims.
- FDA/FTC Join Regulatory Efforts against Hormone-Related Product Claims
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have announced actions against a number of companies marketing unapproved “alternative hormone therapies,” targeting unproven disease claims; FDA said it has sent Warning Letters to 16 dietary supplement and hormone cream marketers; FTC is issuing letters that notify 34 websites that include unsubstantiated claims.
- FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims
Federal Trade Commission staff sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these sellers that their marketing claims may be illegal.
- FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims
Federal Trade Commission staff sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these sellers that their marketing claims may be illegal.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
OTTAWA, Nov. 9 /CNW Telbec/ - Health Canada is warning consumers not to use certain weight loss products from China because they have been found to contain sibutramine, a prescription medication that should only be taken under medical supervision. The products in question are RS Slim & Fit, Xianting Qianzhisu, Menze Qianweisu, Shou Shen Dan-Xiao Nan Wan, Kartien Slimming Herbs Capsules, and Kartien Trimming Formula. None of these products are approved for sale in Canada, and so far have not been found on the Canadian market. While the Hong Kong Government has recalled these products, some might still be available on the market there. Canadians travelling to Asia are therefore warned against purchasing any of these products. Sibutramine is a prescribed medication used for weight loss and should only be taken under the guidance of a health care professional. If used improperly, it could have serious health consequences, including eye pain and eye hemorrhage, increased heart rate and raised blood pressure. People with heart or circulatory system problems should not take sibutramine. It should also not be taken with antidepressants or other medications that can affect the level of serotonin in the brain. Consumers who are currently using any of these herbal weight loss products should stop taking the product immediately. Current and former users who are concerned about their health should contact their health care professional for advice. Canadians should only use drugs and natural health products that have been authorized for sale by Health Canada. Authorized drugs and natural health products will bear either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Drug Number (DIN-HM). This authorization indicates that the products have been assessed by Health Canada for safety, effectiveness and quality. Members of the public are encouraged to inform Health Canada if they are aware of the sale of any of these herbal slimming products. The toll-free number for calls to the Health Products and Food Branch Inspectorate is 1-800-267-9675.
To date, no adverse reactions from the use of these products have been reported in Canada. To report a suspected adverse reaction, please contact the Canadian Adverse Drug Reaction Monitoring Program (CADRMP) of Health Canada by one of the following methods:
|